RECLIP aims to address all the gaps regarding the development of pediatric clinical trials in Spain through a strong, exceptional and super-specialized network of pre-qualified clinical sites. It covers the specific needs of pediatric clinical trials in Spain in a professionalized, multidisciplinary, and organized manner, gathering the most important pediatric clinical research units across the country, corresponding to the most important hospitals of Spain, combined with primary care centers and thematic research networks that develop relevant activity in pediatric clinical research.
Collaborations & Networking
In Spain, specific efforts related to pediatric research are limited, and there is no specific official network or platform for pediatric clinical trials designed to address and change this situation, which is why RECLIP took shape and was launched as an initiative promoted by the clinical representatives of the main pediatric hospitals in Spain and under the coordination and leadership of Prof. Dr. Federico Martinón Torres, Head of the Pediatrics Service of the Hospital Clínico Universitario de Santiago of Compostela.
The official establishment of the network was attended by members of the different institutions founders of the network, representatives of associations of the pharmaceutical industry (FarmaIndustria) and of the Spanish Agency of Medicines and Health Products (AEMPS) and the Carlos III Health Institute (ISCIII), as well as coordinators of existing clinical research networks such as the Maternal and Child Health Network - SAMID, the European Reference Network for Transplants in Children – TRANSCHILD and the Spanish Clinical Research Network – SCReN.
Other entities that have established collaborations with RECLIP are the Medical Association of the Pharmaceutical Industry (AMIFE) and the Spanish Association of Pediatrics (AEP).
Institutional Endorsements and Collaborative Entities
Agencia Española Del Medicamento Y Productos SanitariosMedicines And Healthcare Products Agency
Asociación Española De PediatríaSpanish Association Of Paediatrics
FarmaindustriaNational Trade Association Of The Spanish Based Pharmaceutical Industry
Asociación De Medicina De La Industria Farmacéutica (Amife)Medical Association Of The Pharmaceutical Industry
Red De Investigación Clínica Pediátrica De La Agencia Europea Del MedicamentoEuropean Network Of Paediatric Research At The European Medicines Agency
Under partnerships and through several collaborations RECLIP reaffirms and strengthens its presence with the main European stakeholders. As national hub, RECLIP has partnerships and collaborations with supra-national networks, mainly conect4children (collaborative network for European clinical trials for children - c4c), as well as disease-focused or other specialty networks.
conect4children (collaborative network for European clinical trials for children, c4c) is a large collaborative pediatric network that will facilitate the development of new drugs and other therapies for the entire pediatric population in Europe. RECLIP is the participant national hub in this collaborative network.
c4c aims to enhance the competitiveness of Europe as a critical region for developing medicines for children by using existing expertise, patient access and developing common processes to be applied to disease natural history studies, registries, studies of new therapies and comparisons of existing therapies.
The consortium is a currently a novel collaboration between academic and private sectors that includes 33 academic and 10 industry partners from 20 European countries, more than 50 third parties and around 500 affiliated partners.
The project is coordinated and led by: Fondazione PENTA – for the treatment and care of children with HIV – ONLUS, The University of Liverpool, Janssen Pharmaceutical NV and Bayer AG.
RECLIP is classified as a member category 1 of EnprEMA.
The European Network of Pediatric Research at the European Medicines Agency, Enpr-EMA, is a network constituted by research networks, investigators and centres/sites with recognised expertise in performing clinical studies in children.
According to the evaluation received, RECLIP meets the required criteria established by EnprEMA to be awarded with the máximum category, bringing RECLIP at the top of the pediatric clinical research together with other outstanding networks across Europe. RECLIP has been recently (March 2022) succesfully re-evaluated as EnprEMA Category 1 member.
Through this joint effort we work to ensure that safe and effective clinical trials are designed and conducted for the pediatric population.